A unique case of very low-dose subcutaneous ketamine use: Maintenance option of ketamine for treatment-resistant depression

被引：1

作者：

Can, Adem T. T. ^{[1
]}

Hermens, Daniel F. F. ^{[1
]}

Lagopoulos, Jim ^{[1
]}

机构：

[1] Univ Sunshine Coast, Thompson Inst, Birtinya, QLD, Australia

来源：

CLINICAL CASE REPORTS | 2022年 / 10卷 / 12期

关键词：

depression; ketamine; MADRS; NMDA; suicidality; treatment-resistant; TRIAL; DISORDER; STRESS;

D O I：

10.1002/ccr3.6675

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Numerous studies have demonstrated that low-dose subanesthetic intravenous ketamine infusion treatment leads to rapid improvement of treatment-resistant depression. The following case report describes the use of a very low-dose subcutaneous ketamine as a form of maintenance in a patient with severe treatment-resistant depression using a retrospective chart review.

引用

页数：6

共 50 条

[31] SUICIDALITY IN TREATMENT RESISTANT DEPRESSION: PERSPECTIVE FOR KETAMINE USE [J].

Jakuszkowiak-Wojten, Katarzyna ;

Galuszko-Wegielnik, Maria ;

Wilkowska, Alina ;

Slupski, Jakub ;

Wlodarczyk, Adam ;

Gorska, Natalia ;

Szarmach, Joanna ;

Szalach, Lukasz P. ;

Wiglusz, Mariusz S. ;

Krysta, Krzysztof ;

Cubala, Wieslaw Jerzy .

PSYCHIATRIA DANUBINA, 2019, 31 :S258-S260

[32] Understanding the variability in ketamine's efficacy in managing treatment-resistant depression [J].

Bryan, Joshua W. .

DISCOVER PSYCHOLOGY, 2024, 4 (01)

[33] Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression [J].

Eric P. McMullen ;

Yena Lee ;

Orly Lipsitz ;

Leanna M. W. Lui ;

Maj Vinberg ;

Roger Ho ;

Nelson B. Rodrigues ;

Joshua D. Rosenblat ;

Bing Cao ;

Hartej Gill ;

Kayla M. Teopiz ;

Danielle S. Cha ;

Roger S. McIntyre .

Advances in Therapy, 2021, 38 :2795-2820

[34] A comparison of the safety, feasibility, and tolerability of ECT and ketamine for treatment-resistant depression [J].

Tamman, Amanda ;

Anand, Amit ;

Mathew, Sanjay J. .

EXPERT OPINION ON DRUG SAFETY, 2022, 21 (06) :745-759

[35] Association of Neurofilament Light Chain With the Antidepressant Effects of Low-Dose Ketamine Infusion Among Patients With Treatment-Resistant Depression [J].

Lin, Wei-Chen ;

Su, Tung-Ping ;

Li, Cheng-Ta ;

Wu, Hui-Ju ;

Bai, Ya-Mei ;

Liu, Yu-Li ;

Tu, Pei-Chi ;

Chen, Mu-Hong .

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2023, 26 (09) :649-653

[36] Pilot Randomized Controlled Trial of Titrated Subcutaneous Ketamine in Older Patients with Treatment-Resistant Depression [J].

George, Duncan ;

Galvez, Veronica ;

Martin, Donel ;

Kumar, Divya ;

Leyden, John ;

Hadzi-Pavlovic, Dusan ;

Harper, Simon ;

Brodaty, Henry ;

Glue, Paul ;

Taylor, Rohan ;

Mitchell, Philip B. ;

Loo, Colleen K. .

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 25 (11) :1199-1209

[37] Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression [J].

Acevedo-Diaz, Elia E. ;

Cavanaugh, Grace W. ;

Greenstein, Dede ;

Kraus, Christoph ;

Kadriu, Bashkim ;

Zarate, Carlos A. ;

Park, Lawrence T. .

JOURNAL OF AFFECTIVE DISORDERS, 2020, 263 :568-575

[38] High-dose Versus Low-dose Oral Ketamine on Control and Relapse of Treatment-resistant Depression: A Randomized, Double-blinded Clinical Trial [J].

KheirAbadi, Gholamreza ;

Golkar, Shirin .

IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2023, 17 (04)

[39] Somatic Comorbidities and Cardiovascular Safety in Ketamine Use for Treatment-Resistant Depression [J].

Szarmach, Joanna ;

Cubala, Wieslaw Jerzy ;

Wlodarczyk, Adam ;

Galuszko-Wegielnik, Maria .

MEDICINA-LITHUANIA, 2021, 57 (03)

[40] Ketamine augmentation rapidly improves depression scores in inpatients with treatment-resistant bipolar depression [J].

Rybakowski, Janusz K. ;

Permoda-Osip, Agnieszka ;

Bartkowska-Sniatkowska, Alicja .

INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2017, 21 (02) :99-103

← 1 2 3 4 5 →